KMTS
Income statement / Annual
Last year (2025), KESTRA MEDICAL TECHNOLOGIES, LTD.'s total revenue was $59.82 M,
an increase of 115.05% from the previous year.
In 2025, KESTRA MEDICAL TECHNOLOGIES, LTD.'s net income was -$113.81 M.
See KESTRA MEDICAL TECHNOLOGIES, LTD.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2021
|
FY-2020
|
| Period Ended |
04/30/2025 |
04/30/2024 |
04/30/2023 |
04/30/2021 |
04/30/2020 |
| Operating Revenue |
$59.82 M |
$27.81 M |
$7.63 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$35.61 M
|
$27.45 M
|
$18.28 M
|
$0.00
|
$0.00
|
| Gross Profit |
$24.21 M
|
$362.00 K
|
-$10.65 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.4
|
0.01
|
-1.4
|
0
|
0
|
| Research and Development Expenses |
$15.65 M
|
$15.49 M
|
$15.76 M
|
$18.81 M
|
$22.80 M
|
| General & Administrative Expenses |
$0.00
|
$29.25 M
|
$19.10 M
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$40.68 M
|
$34.92 M
|
$13.90 M
|
$6.52 M
|
| Selling, General & Administrative Expenses |
$114.94 M
|
$69.94 M
|
$54.01 M
|
$13.90 M
|
$6.52 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$130.59 M
|
$85.43 M
|
$69.77 M
|
$32.71 M
|
$29.32 M
|
| Cost And Expenses |
$166.19 M
|
$112.88 M
|
$88.05 M
|
$32.71 M
|
$29.32 M
|
| Interest Income |
$3.20 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$7.73 M
|
$6.23 M
|
$5.63 M
|
$1.17 M
|
$0.00
|
| Depreciation & Amortization |
$7.97 M
|
$11.56 M
|
$4.86 M
|
$420.00 K
|
$478.00 K
|
| EBITDA |
-$97.98 M |
-$76.31 M |
-$73.74 M |
-$32.33 M |
-$28.84 M |
| EBITDA Ratio |
-1.64
|
-2.74
|
-9.66
|
0
|
0
|
| Operating Income Ratio |
-1.78
|
-3.06
|
-10.54
|
0
|
0
|
| Total Other Income/Expenses Net |
-$7.30 M
|
-$9.03 M
|
-$3.80 M
|
-$1.21 M
|
$0.00
|
| Income Before Tax |
-$113.68 M
|
-$94.10 M
|
-$84.22 M
|
-$33.91 M
|
-$29.32 M
|
| Income Before Tax Ratio |
-1.9
|
-3.38
|
-11.04
|
0
|
0
|
| Income Tax Expense |
$135.00 K
|
$24.00 K
|
$15.00 K
|
$187.00 K
|
$148.00 K
|
| Net Income |
-$113.81 M
|
-$94.12 M
|
-$84.24 M
|
-$34.10 M
|
-$29.47 M
|
| Net Income Ratio |
-1.9
|
-3.38
|
-11.04
|
0
|
0
|
| EPS |
-5.13 |
-2.04 |
-1.75 |
-0.69 |
-0.59 |
| EPS Diluted |
-5.13 |
-2.04 |
-1.75 |
-0.69 |
-0.59 |
| Weighted Average Shares Out |
$49.53 M
|
$49.53 M
|
$49.53 M
|
$49.53 M
|
$49.53 M
|
| Weighted Average Shares Out Diluted |
$49.53 M
|
$49.53 M
|
$49.53 M
|
$49.53 M
|
$49.53 M
|
| Link |
|
|
|
|
|
